NCT01479972 Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa Status COMPLETED Phase PHASE2
NCT01464762 Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis Status APPROVED_FOR_MARKETING Phase N/A
NCT01459120 Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho Status COMPLETED Phase NA
NCT01456845 Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity Status COMPLETED Phase N/A
NCT01442428 Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial Status WITHDRAWN Phase PHASE2/PHASE3
NCT01436929 Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs Status UNKNOWN Phase NA
NCT01433796 Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment Status COMPLETED Phase N/A
NCT01424501 Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease Status TERMINATED Phase PHASE2
NCT01422798 An Open Cohort of Childhood Tuberculosis in Mbarara National Referral Hospital, Uganda Status COMPLETED Phase N/A
NCT01417988 Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment Status TERMINATED Phase PHASE4
NCT01404312 Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB) Status COMPLETED Phase PHASE3
NCT01376843 Conversion Rate of (TST) Tuberculin Skin Test and Quantiferon-TB Gold In Tube Assay in Health Care Workers Status COMPLETED Phase N/A